AI in Regenerative Medicine: Can Technology Help Preserve Your Joints?
- cassis101
- 3 days ago
- 7 min read
By Deborah Westergaard, M.D. Dallas | Regen Experts Dallas & Plano
Can Technology Help Preserve Your Joints?
Lately, I have noticed something interesting.
My patients are asking me about artificial intelligence—not with fear, but with genuine curiosity.
Recently, a patient looked up from his phone and asked:
“So, how long before the computer does my injection?”
He was joking. Mostly.
He had seen a headline about artificial intelligence designing new molecules and wanted to know what it might mean for his knee. The question was lighthearted, but it reflects something important: patients are beginning to understand that AI may change medicine. What they want to know is whether it can help them remain active, avoid unnecessary surgery, and preserve the joints they will depend on for decades.
The answer is promising—but more nuanced than the headline.
AI in Regenerative Medicine Is Advancing Faster Than Many People Realize
Anthropic recently reported that Claude models were given a written protocol for de novo protein-binder design. A protein binder is a newly designed molecule intended to attach to a particular surface on a target protein.
The models researched the targets, selected potential binding sites, installed and operated established open-source protein-design tools, generated candidate structures and sequences, optimized them computationally, and ranked the final designs.
Independent laboratories then synthesized and tested the designs. According to Anthropic’s technical report, 354 of 1,320 tested designs bound their intended targets, and at least one binder was identified for 14 of the 15 targets with interpretable data.
That is a meaningful development. It suggests that AI may substantially accelerate an early phase of biological discovery that traditionally requires considerable time, specialized expertise, and repeated computational work.
For regenerative medicine, the long-term implications could be important. Faster protein design may eventually contribute to better research tools, new biological targets, and novel therapeutics intended to influence inflammation, tissue signaling, or repair.
However, “eventually” matters.
The Problem: A Designed Protein Is Not Yet a Treatment
A binder is not the same as an approved drug. Binding to a target does not prove that a molecule will produce a beneficial biological effect, reach the appropriate tissue, remain safe in the human body, or improve pain and function.
Before a designed molecule becomes a treatment, researchers must still investigate questions such as:
Does it change the target’s function in the desired way?
Is it selective, stable, and reproducible?
Could it produce unintended effects elsewhere in the body?
Can it reach the intended tissue at an appropriate concentration?
Is it safe and effective in preclinical and human studies?
The Anthropic researchers themselves emphasized a central limitation: the experiment demonstrated binding, not biological function or clinical benefit.
That distinction is essential. It is also why a dramatic scientific headline should not be mistaken for a treatment that is ready for your knee, hip, shoulder, or spine.
The Real Joint-Preservation Problem Is More Than a Molecule
When someone is told that a joint is “bone-on-bone,” the conversation can feel as though the future has already been decided. Yet an MRI phrase is not a complete diagnosis, and pain does not always arise from one structure alone.
A painful knee may involve cartilage loss, but it may also include a meniscal tear, an unstable ligament, a bone-marrow lesion beneath the cartilage, altered alignment, tendon dysfunction, or a combination of these findings.
The same principle applies to the hip and shoulder. A procedure directed only into a joint may miss an important tendon, labrum, ligament, or area of subchondral bone. Conversely, imaging abnormalities that are not clinically relevant should not automatically be treated.
This is the gap that technology has not closed.
AI can analyze patterns and help organize complex information. It may eventually become excellent at predicting which patients are more likely to respond to particular interventions. But the decision still requires someone to connect the imaging with the examination, the biomechanics, the patient’s health, and the activity that person hopes to regain.
For one patient, the goal may be returning to golf without swelling afterward. For another, it may be traveling with a spouse, running a company without being distracted by pain, exercising for long-term health, or getting down on the floor with grandchildren—and being able to stand back up.
Joint preservation is not simply about treating an image. It is about protecting capability.
The Solution: Precision Orthobiologics in Dallas Guided by Clinical Judgment
The most valuable role of AI in regenerative medicine may not be replacing the physician. It may be strengthening the physician’s ability to make a more informed, individualized decision.
In my Dallas-area practice, the joint-preservation process begins with a detailed evaluation rather than a predetermined procedure. Depending on the clinical question, that may include a focused examination, review of MRI and X-ray findings, diagnostic musculoskeletal ultrasound, and consideration of alignment, stability, prior treatment, and functional goals.
Only then can we ask the questions that matter:
Which structure is most likely contributing to the pain?
Is there a mechanical problem that should be addressed?
Does the imaging identify more than one relevant tissue?
Is an orthobiologic procedure reasonable, or would another approach be more appropriate?
If treatment is considered, what form of image guidance provides the precision and safety the anatomy requires?
Orthobiologic procedures may use a patient’s own platelet or bone-marrow-derived preparations as part of a carefully selected, image-guided treatment plan. They are not guaranteed to restore cartilage, eliminate pain, or prevent surgery. Outcomes vary with the diagnosis, tissue condition, severity of degeneration, age, health, biomechanics, rehabilitation, and other individual factors.
That is precisely why experience and judgment matter.
Excellence in medicine is not doing the newest procedure simply because it is available. It is choosing carefully, planning precisely, and being willing to say when a treatment is unlikely to provide meaningful value.
Quality means understanding what is being treated and why.
Resilience means helping patients pursue function even after pain or degeneration has changed their plans.
Transformation begins when a patient moves from reacting to pain toward making an informed strategy for long-term mobility.
Can AI Decide Whether You Are a Candidate for Joint-Preservation Treatment?
Not by itself.
AI may increasingly assist with imaging analysis, patient selection, outcome tracking, rehabilitation, and treatment research. Those tools could improve consistency and reveal patterns that physicians might otherwise miss.
However, an algorithm does not yet integrate every meaningful element of a patient’s story under live clinical conditions. It cannot independently determine the correct tissue, plane, depth, approach, or treatment priority for a particular patient on a particular day.
Most importantly, it does not carry responsibility for the decision.
Patients deserve more than technological enthusiasm. They deserve a physician who understands emerging science, recognizes its limitations, and applies it only when it supports a thoughtful clinical plan.
What May Change First in Orthobiologics?
AI is likely to influence orthobiologics in several stages:
Molecule and target discovery: AI may accelerate the design and screening of proteins and other therapeutic candidates.
Patient selection: Predictive models may help identify which clinical and imaging patterns correlate with better outcomes.
Imaging interpretation: AI may help quantify cartilage, tendon, bone, and structural changes more consistently over time.
Outcome tracking: Better analysis of real-world data may show which approaches perform best for particular patient profiles.
Procedure planning: AI may eventually support trajectory planning and anatomic recognition, while the treating physician remains responsible for execution and safety.
The future will likely combine computational speed with clinical discernment—not ask patients to choose between them.
Call to Action: Do Not Wait for AI to Start Protecting Your Mobility
You do not need to wait for the next generation of technology to begin asking better questions about your joint.
If knee, hip, shoulder, or spine pain is limiting the way you exercise, travel, work, or participate in family life, the first step is not automatically an injection—and it is not automatically surgery.
The first step is a precise evaluation.
At Regen Experts, I evaluate patients from Dallas, North Dallas, Preston Center, Plano, and surrounding communities who want to understand whether a nonoperative joint-preservation strategy may be appropriate. The goal is not to promise that every joint can be saved. The goal is to identify the structures involved, explain the reasonable options, and help each patient make a well-informed decision about protecting function and longevity.
Schedule a joint-preservation consultation with Dr. Deborah Westergaard to determine whether precision orthobiologics may be appropriate for your diagnosis and goals.
This article is for educational purposes only and does not constitute medical advice. Orthobiologic procedures are not appropriate for every patient, and individual outcomes cannot be guaranteed. Treatment recommendations require an individualized medical evaluation.
Frequently Asked Questions
What is de novo protein-binder design?
It is the computational creation of a new protein intended to attach to a selected site on another protein. Binding is an early research result; it does not by itself establish safety, biological activity, or effectiveness as a treatment.
Is AI currently performing orthobiologic injections?
AI can assist with research, imaging analysis, data interpretation, and potentially procedure planning. The evaluation, treatment decision, and image-guided procedure still require qualified clinical oversight and individualized judgment.
Can regenerative medicine prevent joint replacement?
No procedure can guarantee avoidance of joint replacement. Some appropriately selected patients may consider orthobiologic treatment as part of a nonoperative joint-preservation plan, while others may be better served by surgery or another form of care.
What are orthobiologics?
Orthobiologics are biological preparations used in musculoskeletal care. Common examples include platelet-rich plasma and certain same-day preparations derived from a patient’s own bone marrow. Their appropriateness depends on the diagnosis, treatment objective, and individual patient factors.
Why is image guidance important for orthobiologic procedures?
Ultrasound or fluoroscopy can help the physician identify anatomy and place a needle in the intended location. The most appropriate guidance method depends on the structure, depth, anatomy, and procedure being performed.
#Orthobiologics #RegenerativeMedicineDallas #AIinMedicine #JointPreservation #Regenexx #InterventionalPain #BackpainDallas #BackpainPlano
Comments